Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Antengene presents clinical trial results for oncology pipeline at ESMO

Biotechnology company Antengene Corporation presented updated clinical data for drug candidates ATG 022 and ATG 037 during the ESMO 2026 Congress in Madrid

We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.

Read the original at vir.com.vn →

More in Health & Medicine

More from Monday 26 October →